|
½ÃÀ庸°í¼
¿ÜºÎ ¼Ò½º¸¦ ÀÌ¿ëÇÑ Á¶±â ÆÄÀÌÇÁ¶óÀÎ ±¸Ãà Àü·«
Strategies for Building Early-Stage Pipelines Through External Sources
|
Decision Resources, Inc. ¿¡¼ 2009³â 07¿ù ¿¡ ¹ßÇàÇÑ ¡¸¿ÜºÎ ¼Ò½º¸¦ ÀÌ¿ëÇÑ Á¶±â ÆÄÀÌÇÁ¶óÀÎ ±¸Ãà Àü·«¡¹ º¸°í¼´Â 29 Pages·Î ±¸¼ºµÇ¾î, US $3,450 ºÎÅÍ ±¸¸Å °¡´ÉÇÕ´Ï´Ù.
¾àÁ¦ °³¹ß ÆÄÀÌÇÁ¶óÀÎÀÇ Áõ°°ú ¿¬±¸ °³¹ßÀÇ »ý»ê¼º Çâ»óÀ» À§ÇØ Á¦¾àȸ»ç´Â ¿ÜºÎ ¼Ò½º¸¦ Ȱ¿ëÇÑ Á¦Ç° °³¹ß°ú ±â¼ú Çõ½ÅÀ» ¸ð»öÇϰí ÀÖ½À´Ï´Ù. ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷ÀÌ Á¦°øÇÏ´Â °¡Ä¡ÀÖ´Â ±â¼ú°ú Ç¥Àû, ÈÇÕ¹°À» ÀÌ¿ëÇÑ »õ·Î¿î ºñÁî´Ï½º ¸ðµ¨ÀÇ °³¹ßÀ» ÅëÇØ °æÇÕ¼ºÀ» ³ôÀÌ·Á Çϰí ÀÖ½À´Ï´Ù. Á¶±â ÆÄÀÌÇÁ¶óÀÎ ±¸ÃàÀÇ Çʿ伺°ú ±×°ÍÀ» À§ÇÑ Á¦ÈÞ Àü·«, ÁÖ¸ñ¹Þ´Â ±â¼ú°ú ¾÷°èÀÇ ÇâÈÄ Àü¸Á µî¿¡ ´ëÇØ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. 3. ±â¼ú Çõ½Å Á¢±Ù Àü·« - ÇÕº´ ¹× ¸Å¼ö
- ±â¾÷°£ Á¦ÈÞ
- Çмú±â°ü°úÀÇ Çù·Â
4. Á¦ÈÞ¸¦ ÅëÇÑ Á¶±â ÆÄÀÌÇÁ¶óÀÎ ±¸Ãà Àü·« 5. ÁÖ¸ñÇØ¾ß ÇÒ °Å·¡ µ¿Çâ - Genentech/Bayhill Therapeutics
- Boehringer Ingelheim/Vitae Pahrmaceuticals
- GlaxosmithKline/Concert Pharmaceuticals
- Sanofi-Aventis/Exelixis
- Wyeth/Santaris Pharma
- Alnylam/Takeda
- Merck/GlycoFi
LSH
|